Alivio
NDC Package 69512-600-90

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Alivio is iNDICATIONS AND USAGECarefully consider the potential benefits and risks of ibuprofen tablets and other treatment optionsbefore deciding to use ibuprofen tablets. Marketed by Alivio Medical Products, Llc, this product is identified by NDC 69512-600 and is authorized under FDA application ANDA090796.

Identification & Billing

NDC Package Code
69512-600-90
Package Description
90 BOTTLE in 1 BOTTLE / 54000 mg in 1 BOTTLE
Product Code
11-Digit Billing Format
69512060090
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA
RxNorm Crosswalk
RxCUI: 197806 - ibuprofen 600 MG Oral Tablet

Clinical Specifications

Proprietary Name
Alivio
Dosage Form
-
Usage Information
INDICATIONS AND USAGECarefully consider the potential benefits and risks of ibuprofen tablets and other treatment optionsbefore deciding to use ibuprofen tablets. Use the lowest effective dose for the shortest durationconsistent with individual patient treatment goals (see WARNINGS). Ibuprofen tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis andosteoarthritis.Ibuprofen tablets are indicated for the relief of mild to moderate pain.Ibuprofen tablets are also indicated for the treatment of primary dysmenorrhea.Controlled clinical trials to establish the safety and effectiveness of ibuprofen tablets in children have not been conducted.

Regulatory & Marketing

Labeler Name
Alivio Medical Products, Llc
FDA Application #
ANDA090796
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
07-01-2015
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69512-600-90 identifies a specific commercial package of 90 bottle in 1 bottle / 54000 mg in 1 bottle of Alivio, labeled by Alivio Medical Products, Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Alivio Medical Products, Llc on July 01, 2015. The current certification is valid through December 31, 2017.

How is this Alivio Medical Products, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69512060090. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69512-600-90
11-Digit CMS (5-4-2)
69512-0600-90

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.